Kayentis
PrivateLast Round
VC Round
Mar 28, 2023
Total Funding Raised
$19.85M
Company Overview
Kayentis is a healthtech company that provides electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial (DCT) solutions for the collection of clinical trial data from patients and sites.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kayentis Comps
Public and private peers based on sector, stage, and business model.
Kayentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 28, 2023 | ||||
| Debt | Mar 28, 2023 | ||||
| Growth Equity | Dec 2, 2020 | ||||
| Growth Equity | Oct 13, 2016 | ||||
| VC Round | Feb 1, 2015 | ||||
Series C | Sep 1, 2007 |
Key People
Founding team and executive leadership
Kayentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Growth Equity, VC Round |
| Innovation Capital | Growth Equity |
| Extens | Growth Equity, VC Round |
| LBO France | VC Round, Growth Equity |
| Seventure Partners | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Opened new office in Tokyo, adding to Grenoble and Boston locations.
- Jan 1, 2025
Supported over 350 trials for 150,000+ patients in 90 countries.
Kayentis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kayentis's valuation, stock price, and market status.